
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. The company is part of Johnson & Johnson Innovative Medicine business segment. Derived from Wikipedia licensed CC-BY-SA.
Open Access statistics for Actelion (Switzerland), Switzerland, covering academic research published from 2000 to 2024. Read More.
Open Access Percentage
39%
Total
Publications
1.2K
Total Open
Publications
483
Total
Citations
57K
Open Access
Percentage
39%
Total
Publications
1.2K
Total Open
Publications
483
Total
Citations
57K
Breakdown
Publisher Open
17%
Both
20%
Other Platform Open
2%
Closed
61%
Percentage of Open Access over time
Publisher Open
Both
Other Platform Open
Closed
Volume of Open Access over time
Open
Closed
Publisher Open
OA Journal 36%
163
Hybrid 24%
107
No Guarantees 40%
183
Other Platform Open
Domain 65%
184
Institution 28%
80
Other Internet 28%
79
Public 5%
13
Preprint 2%
5
Other Platform Locations
Name | Platform Type | Publications |
|---|---|---|
PubMed Central | Domain | 184 |
DOI | Other Internet | 80 |
Europe PMC | Domain | 15 |
Royal Netherlands Academy of Arts and Sciences | Institution | 13 |
Istituto di Ematologia di Bologna | Institution | 13 |
Figshare | Public | 10 |
University of Melbourne | Institution | 9 |
University College of Arts Crafts and Design | Institution | 9 |
University of Geneva | Institution | 5 |
University of Michigan–Ann Arbor | Institution | 4 |